Student Name
Capella University
NURS-FPX4055 Optimizing Population Health through Community Practice
Prof. Name
Date
Health Promotion Plan Presentation
Good morning and welcome. We appreciate the presence of our community partners for today’s health session. The primary focus of this presentation is to address the prevention of Human Papillomavirus (HPV) infections among adolescents and young adults aged 11 to 26, residing in Schwenksville, Pennsylvania. Our discussion today is grounded in the SMART goals we collaboratively established and is aligned with the objectives of Healthy People 2030. The session will explore key facts about HPV, its connection to cancer, the importance of timely vaccination, and strategies for effectively communicating with healthcare providers and family members about the HPV vaccine.
The flow of the presentation will include several components: presenting essential facts about HPV and its link to cancer; highlighting the safety, efficacy, and benefits of HPV vaccination; motivating attendees to schedule a vaccination within 30 days; increasing confidence in discussing the vaccine with trusted individuals; engaging in interactive learning; and concluding with an evaluation of knowledge and confidence through a quiz and survey. These steps will ensure a comprehensive understanding and actionable outcomes for participants.
Presentation Overview Table
| Session Segment | Objective |
|---|---|
| Key Facts on HPV | Educate on HPV transmission and cancer correlation |
| Importance of Vaccination | Emphasize vaccine benefits, timing, and safety |
| Call to Action | Encourage scheduling of vaccination |
| Communication Strategies | Build confidence to discuss HPV vaccination |
| Engagement Activities | Promote active participation and retention |
| Post-Session Assessment | Evaluate comprehension and communication confidence |
HPV is a widespread virus, primarily transmitted through sexual contact and skin-to-skin interaction. In Pennsylvania, about 68.7% of adolescents have completed HPV vaccination, with lower rates in rural regions like Schwenksville, where the figure stands at 48.7% (PA.gov, 2025). These lower vaccination rates correspond to increased risks of HPV-associated cancers in the region, making awareness campaigns and access to immunization especially vital. Persistent infection with high-risk HPV strains, such as types 16 and 18, is the leading cause of cervical, anal, and oropharyngeal cancers (Huber et al., 2021). While most HPV infections resolve naturally, some can lead to cell changes and cancer. Early and regular screening, combined with vaccination, offers strong defense against these risks.
Benefits and Communication Strategies
Timely HPV vaccination is crucial for effective protection. Administering the vaccine around ages 11 or 12, prior to any sexual exposure, results in a robust immune response that offers long-term protection (Hoes et al., 2021). Early immunization not only prevents cervical cancer—the second most common cancer among women globally—but also protects against other HPV-associated cancers such as penile, anal, and throat cancers, which affect both genders (Cheng et al., 2020). Additionally, the vaccine helps prevent genital warts, contributing to improved emotional well-being and reduced stigma. Community-level vaccination further reduces the virus’s prevalence, contributing to herd immunity and safeguarding vulnerable populations (Xu et al., 2024).
To effectively encourage HPV vaccination, it is essential to employ strategic communication techniques. First, using fact-based, scientifically backed information from sources like the CDC or WHO fosters credibility and dispels myths. Second, asking insightful questions during medical consultations, such as inquiries about the vaccine’s long-term benefits, initiates productive dialogue. Third, addressing prevalent myths—like the false idea that vaccination encourages early sexual activity—can be tackled calmly by emphasizing the vaccine’s role in cancer prevention. These communication tools help families make informed decisions and overcome hesitancy.
Table: Summary of HPV Vaccination Benefits
| Benefit | Description |
|---|---|
| Stronger Immune Response | Early vaccination results in higher efficacy and longer protection |
| Cancer Prevention | Reduces risk of cervical, anal, penile, and oropharyngeal cancers |
| Genital Wart Reduction | Prevents painful, stigmatized symptoms associated with some HPV strains |
| Community Immunity | Decreases virus transmission rates within the community |
| Lower Healthcare Burden | Reduces long-term costs and mortality associated with HPV-related diseases |
Evaluation of SMART Goals and Healthy People 2030 Alignment
This health education session was designed with specific SMART goals to measure success. Our first objective was for at least 90% of participants to identify three or more key facts about HPV and cancer. This was met, as 92.5% demonstrated accurate knowledge during the post-session quiz. The second goal aimed for 80% of eligible participants to commit to scheduling an HPV vaccination within 30 days. While a commendable 75% made verbal commitments, this fell slightly short. The third goal—to increase confidence in discussing HPV vaccination—was achieved, with 85% of participants reporting improved confidence in communication with healthcare providers and family members.
SMART Goals and Outcomes Table
| SMART Goal | Target | Outcome | Remarks |
|---|---|---|---|
| Knowledge of HPV-Cancer Link | 90% | 92.5% | Goal exceeded; strong participant understanding |
| Vaccination Commitment | 80% | 75% | Slight shortfall; follow-up discussion with families suggested |
| Confidence in Communication | 85% | 85% | Goal met; role-playing may further enhance communication readiness |
Despite overall success, some gaps were evident. Adolescents, in particular, expressed uncertainty about committing to vaccination without consulting their parents. A few also reported discomfort in challenging misinformation. To improve future sessions, three enhancements are suggested: integrate family discussions during the session; provide hands-on myth-busting exercises; and extend session length or offer follow-up meetings to support decision-making.
Regarding Healthy People 2030 objectives, the session made notable strides in increasing awareness and promoting preventive behavior. Key goals include raising HPV vaccine uptake among adolescents and decreasing HPV-related cancer rates (U.S. Department of Health and Human Services, n.d.). With 92.5% knowledge attainment and 85% communication confidence, we are advancing toward these public health goals. However, the shortfall in vaccination pledges highlights a need for additional interventions. By involving families, reinforcing vaccine safety with current evidence, and ensuring continued engagement post-session, future educational efforts will more effectively align with national targets.
Conclusion
In summary, this health promotion presentation emphasized the importance of HPV vaccination in protecting the long-term health of adolescents and young adults in Schwenksville, PA. Through education, engagement, and clear goal setting, we increased knowledge and encouraged preventive action. While some participants require more support to make vaccination decisions, our session made significant progress in aligning with SMART goals and Healthy People 2030 benchmarks. Continued community involvement and session improvements will further strengthen efforts to reduce HPV-related disease burden.
References
Cheng, L., Wang, Y., & Du, J. (2020). Human papillomavirus vaccines: An updated review. Vaccines, 8(3), 391. https://doi.org/10.3390/vaccines8030391
Hoes, J., Pasmans, H., Schurink-van ’t Klooster, T. M., van der Klis, F. R. M., Donken, R., Berkhof, J., & de Melker, H. E. (2021). HPV vaccination: Long-term effectiveness and immunity in adolescents. Vaccine, 39(9), 1319–1326. https://doi.org/10.1016/j.vaccine.2020.12.065
Huber, L. R., Liu, J., Choi, Y. S., & Garcia, S. G. (2021). Preventing cervical cancer through HPV vaccination: The role of community-based education. Journal of Women’s Health, 30(5), 645–653. https://doi.org/10.1089/jwh.2020.8623
Kassymbekova, D., Walker, T. Y., & Markowitz, L. E. (2023). Barriers to HPV vaccine uptake and strategies for overcoming them. Preventive Medicine Reports, 31, 102072. https://doi.org/10.1016/j.pmedr.2023.102072
NURS FPX 4055 Assessment 4 Health Promotion Plan Presentation
U.S. Department of Health and Human Services. (n.d.). Healthy People 2030: Increase the proportion of adolescents who get recommended doses of the HPV vaccine. Retrieved from https://health.gov/healthypeople/objectives-and-data/browse-objectives/vaccination/increase-proportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08
Xu, H., Chang, T., & Peters, J. R. (2024). Community immunity and vaccine hesitancy: Impacts of early HPV vaccination. Public Health Journal, 58(1), 45–54. https://doi.org/10.1016/j.puhe.2024.01.007